Dalbavancin for Successful Treatment of Infective Endocarditis Caused by Enterococcus faecalis
Open Access
- 3 February 2023
- journal article
- research article
- Published by SMC Media in European Journal of Case Reports in Internal Medicine
- Vol. 10 (1) , 003654
Abstract
Infective endocarditis is a relatively uncommon infection that requires a high index of suspicion, which can sometimes delay its diagnosis. It requires several weeks of intravenous antibiotics, which traditionally requires long hospital stays. Dalbavancin is a novel antibiotic with high activity against several Gram-positive pathogens. Its weekly administration allows the outpatient management of complicated infections requiring parenteral treatment, but only a few cases of Enterococcus faecalis endocarditis treated with dalbavancin have been reported in the literature. We here report a case of successful treatment with dalbavancin of an infectious endocarditis caused by E. faecalis.Keywords
This publication has 6 references indexed in Scilit:
- Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard CareAntibiotics, 2020
- Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current AlternativesAntibiotics, 2020
- DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocciAnnals of Clinical Microbiology and Antimicrobials, 2019
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of ViennaClinical Infectious Diseases, 2018
- 2015 ESC Guidelines for the management of infective endocarditisEuropean Heart Journal, 2015
- Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive PathogensClinical Infectious Diseases, 2005